{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/SE0008613731",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Biovica International AB ser. B (First North Sweden: SE0008613731) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nBiovica International AB ser. B is listed on First North Sweden under the ticker SE0008613731. Its ISIN is SE0008613731 and its LEI is 549300VADE1VRR555N78. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 43 filings across 35 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7.0 days. Days from the latest filing to the record date is 14. The latest filing is dated 2026-10-23 and is a Company Announcement. The First North Sweden median cadence gap is 11.0 days, the median filings are 21 and the median latency is 7 days, across 325 issuers. The sector median is not on the record.\n\n## Auditor\n\nThe auditor of record is not on the record, and neither is its location. The record does not carry auditor changes for this register.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move dates for this register. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1 because the chapter's orderability section carries no client categories. The chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names one research house, REDEYE.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/SE0008613731 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://biovica.com/investor-relations/the-share/analyst-coverage/ (coverage)\n- https://mcp.se-cm-kg.ai/record/SSME/SE0008613731 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/SE0008613731",
  "coverage": {
   "count": 1,
   "houses": [
    {
     "analyst": "Filip Lindkvist",
     "house": "REDEYE",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://biovica.com/investor-relations/the-share/analyst-coverage/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://biovica.com/investor-relations/the-share/analyst-coverage/",
     "result": "read: 1 of 2 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual financial report": 1,
    "Changes in board/management/certified adviser/auditor/liquidity provider": 4,
    "Company Announcement": 26,
    "Company description / prospectus": 2,
    "Decisions of general meeting": 2,
    "Financial statement release": 1,
    "Half year financial report": 1,
    "Interim report (Q1 and Q3)": 2,
    "Investor News": 1,
    "Notice to general meeting": 2,
    "Total number of voting rights and capital": 1
   },
   "cadence_median_gap_days": 7,
   "filing_days": 35,
   "filings": 43,
   "latency_days": 14,
   "latest": [
    {
     "category": "Company Announcement",
     "date": "2026-10-23",
     "source": "https://view.news.eu.nasdaq.com/view?id=b4e4d6fd3102a2370c131b77c8b1733a2&lang=en&src=listed",
     "title": "Biovica announces outcome of the rights issue",
     "type": "Company Announcement"
    },
    {
     "category": "Company description / prospectus",
     "date": "2026-10-12",
     "source": "https://view.news.eu.nasdaq.com/view?id=b58a4a30cde66b38566e269ffe0153eb7&lang=en&src=listed",
     "title": "Correction: Biovica clarifies the description of its patent position in the share issue memorandum published on Oct 6, 2026",
     "type": "Company description / prospectus"
    },
    {
     "category": "Company description / prospectus",
     "date": "2026-10-06",
     "source": "https://view.news.eu.nasdaq.com/view?id=b75857ac2ad7aa36a663f523ed47dd535&lang=en&src=listed",
     "title": "Biovica publishes share issue memorandum in connection with the rights issue",
     "type": "Company description / prospectus"
    },
    {
     "category": "Investor News",
     "date": "2026-10-06",
     "source": "https://view.news.eu.nasdaq.com/view?id=b6d8959ebaff61a824444840fcd979832&lang=en&src=listed",
     "title": "Biovica announces change in Pharma Services leadership as it strengthens its Pharma offering",
     "type": "Investor News"
    },
    {
     "category": "Decisions of general meeting",
     "date": "2026-09-30",
     "source": "https://view.news.eu.nasdaq.com/view?id=b6006f2a7b1e0ba2de35424b4fc0b10c6&lang=en&src=listed",
     "title": "Announcement from the extra general meeting in Biovica International AB",
     "type": "Decisions of general meeting"
    }
   ],
   "latest_filing_date": "2026-10-23",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0008613731",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0008613731"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0008613731)",
    "state": "sourced",
    "value": "549300VADE1VRR555N78"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Biovica International AB ser. B"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0008613731"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:3f15d7fa2103fac659acbcde91f90758421f73da27d68dc143f4f04ef909e596",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/SE0008613731",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:3f15d7fa2103fac659acbcde91f90758421f73da27d68dc143f4f04ef909e596",
 "path": "/se/SSME/SE0008613731",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Biovica International AB ser. B is listed on First North Sweden under the ticker SE0008613731. Its ISIN is SE0008613731 and its LEI is 549300VADE1VRR555N78. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 43 filings across 35 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7.0 days. Days from the latest filing to the record date is 14. The latest filing is dated 2026-10-23 and is a Company Announcement. The First North Sweden median cadence gap is 11.0 days, the median filings are 21 and the median latency is 7 days, across 325 issuers. The sector median is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and neither is its location. The record does not carry auditor changes for this register.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move dates for this register. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1 because the chapter's orderability section carries no client categories. The chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names one research house, REDEYE.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0008613731"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://biovica.com/investor-relations/the-share/analyst-coverage/"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/SE0008613731"
  }
 ],
 "title": "Biovica International AB ser. B (SE0008613731) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}